Rocket Lab (NASDAQ: RKLB) jumped 5% to $72.88 in morning trading after landing its largest-ever Electron launch contract alongside a fresh Wall Street initiation.
The deal, struck with Tokyo-based Earth observation company Synspective, covers 20 new Electron missions in a multi-year agreement that sets a commercial record for the launch vehicle.
The Synspective agreement makes the Japanese radar imaging firm Rocket Lab’s largest Electron customer, with missions scheduled annually later this decade from Rocket Lab’s own launch complex.
Sir Peter Beck, Rocket Lab’s founder and chief executive, framed the deal around the appeal of launch independence for satellite operators building out constellations.
“When constellation builders want control over their destiny, they come to Rocket Lab,” Beck stated in the company’s release announcing the agreement.
Coming on top of several multi-launch contracts awarded earlier this year, the Synspective deal pushed Rocket Lab’s total launch backlog past 100 missions for the first time.
Citigroup (NYSE: C) added momentum to the session by initiating coverage of RKLB with a Buy rating and a $105 price target, arriving on the same morning as the contract announcement.
Rivals in the space sector posted far smaller moves, with AST SpaceMobile (NASDAQ: ASTS) rising 2% to $59.80 and SpaceX (NASDAQ: SPCX) gaining just 0.1% to $151.07 despite the contract landing against a direct launch competitor.
The Procure Space ETF (NASDAQ: UFO) advanced only 0.3% to $42.46, and the SPDR S&P 500 ETF Trust (NYSEARCA: SPY) gained 0.3% to $764.90, confirming that the RKLB move was company-specific rather than sector-driven.
The bull case carries a notable gap, however, as Rocket Lab did not disclose the financial terms of the Synspective agreement, leaving the contract’s dollar value unknown to investors.
With missions scheduled years into the future, the revenue tied to RKLB’s expanded backlog remains distant and unquantified, which exposes the current gain to any shift in sentiment toward long-dated growth stories.
Planet Labs (NYSE: PL) shares an Earth observation niche with Synspective, and additional launch contracts from imagery operators could push Rocket Lab’s backlog further beyond the 100-mission threshold in coming quarters.
Investors holding RKLB face a growth story that still requires Rocket Lab to convert a record backlog of signed missions into actual reported revenue before Citigroup’s $105 target becomes a realistic near-term benchmark.
